knowledge -WSS

knowledge

author：comprehensive 2025-09-07 21:52:16 - browse：33613

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Christmas in the PICU brings some surprising joy

WSS

Why health records don't always know when patients are dead

CDC Director Mandy Cohen on transparency, trust, and health

UHS says company favors patients whose insurance pays more

HCA sued by state AG for quality issues at Mission Health

Truvian presents data for its desktop blood

Violet CEO on training clinicians to promote more inclusive care

focus

knowledge

hotspot

Drug repurposing or repositioning? The language matters

How to keep neuroscience’s past racism from being its future

Cancer drug shortages should be causing more outrage

New lawsuit accuses health insurer Cigna of denying claims in bulk

Walensky prepares to leave CDC — and Congress — behind

In the gardens at Boston Children's Hospital, families find sanctuary

The cancer drug shortage isn’t new — and neither are the solutions

Virtual care provider acquires bankrupt Pear's prescription apps

In Memoriam: Notable people who died in 2023

Former reverend arrested for allegedly killing 8

focus

Can sheer will power keep patients alive in their dying hours?

What STAT readers think about the FDA and patient advocacy

Medicare Advantage beneficiaries sue Humana over algorithm use

New lawsuit accuses health insurer Cigna of denying claims in bulk

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Former reverend arrested for allegedly killing 8

explore

explore

knowledge

hotspot